
Release date: 2026-02-13 17:20:01 Article From: Lucius Laos Recommended: 259
Eltrombopag (generic name: Lucius Pharmaceuticals Eltrombopag Olamine Tablets) prices vary depending on factors such as specifications, place of origin, and purchasing channels. This medication is a prescription drug and must be strictly used under medical supervision; do not adjust the dosage or discontinue use on your own.
Drug Specifications: Prices differ between 25mg and 50mg specifications, with larger doses generally resulting in higher single-treatment costs.
Origin Differences: Imported original brand-name drugs are more expensive due to R&D costs and patent protection, while domestic generic drugs, after passing consistency evaluations, are more competitively priced.
Health Insurance Policies: Some regions include this drug in their health insurance reimbursement catalogs, allowing eligible patients partial coverage; consult local medical institutions for details.
Applicable Population: Primarily used for patients with Immune Thrombocytopenia (ITP) and Aplastic Anemia (AA), and requires evaluation by a hematologist before use.
Monitoring During Treatment: Regular platelet count checks are necessary during treatment to avoid excessive dosing, which may lead to thrombotic risks.
Contraindications and Side Effects: Use with caution in patients with liver dysfunction. Common side effects include headache and nausea; seek medical attention promptly if abnormalities occur.
Offline Channels: Purchase from hospitals or licensed pharmacies to ensure reliable drug sources.
Online Drug Purchase: Some internet hospitals support online consultations followed by prescription issuance; choose legitimate platforms.
Patient Assistance Programs: Certain pharmaceutical companies or charitable organizations offer medication subsidies; patients facing financial difficulties can consult their primary physicians.
This medication requires long-term use. Patients should choose a treatment plan under the guidance of their doctor, considering their individual condition and economic circumstances. Do not trust low-cost drugs from unregulated channels to avoid medication risks.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643